1 / 6

2014-2017 Global and China Stem Cell Industry Report

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment of cardiovascular diseases, leukemia (a kind of hematological system disease), nervous system diseases, damage or lesion of liver, kidney and other parenchymal organs, etc. Currently, cord blood bank is the fastest-growing and relatively mature market amid stem cell upstream sectors and even the whole industry chain. In 2005, there were 23 cord blood banks worldwide and in 2013 the figure exceeded 480. Global cord blood stem cell (CBSC) storage companies can be roughly divided into two categories: the ones running in a globalized business model, such as Cryo-Cell International and Esperite (formerly known as Cryo-Save Group), and the others giving priority to regional operation e.g. Zhongyuan Union Stem Cell Bioengineering (VCANBIO), Golden Meditech and LifeCell International. However, the companies mainly engaged in cord blood bank business are currently small in scale, only a few with more than 500,000 clients. View Complete Report @ http://www.chinamarketresearchreports.com/114908.html .

priyalclinton
Télécharger la présentation

2014-2017 Global and China Stem Cell Industry Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global and China Stem Cell Industry Report, 2014-2017byResearch in China Published: September 2014 No of Pages: 101 Single User PDF: US$ 2250 Corporate User PDF: US$ 3500 View Complete Report @ http://www.chinamarketresearchreports.com/114908.html

  2. Global and China Stem Cell Industry Report, 2014-2017 Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment of cardiovascular diseases, leukemia (a kind of hematological system disease), nervous system diseases, damage or lesion of liver, kidney and other parenchymal organs, etc. Currently, cord blood bank is the fastest-growing and relatively mature market amid stem cell market upstream sectors and even the whole industry chain. In 2005, there were 23 cord blood banks worldwide and in 2013 the figure exceeded 480. Global cord blood stem cell (CBSC) storage companies can be roughly divided into two categories: the ones running in a globalized business model, such as Cryo-Cell International and Esperite (formerly known as Cryo-Save Group), and the others giving priority to regional operation. Buy a Copy of this Report @ http://www.chinamarketresearchreports.com/contacts/purchase.php?name=114908 .

  3. Global and China Stem Cell Industry Report, 2014-2017 Eg. Zhongyuan Union Stem Cell Bioengineering (VCANBIO), Golden Meditech and LifeCell International. However, the companies mainly engaged in cord blood bank business are currently small in scale, only a few with more than 500,000 clients. The stem cell technology and product research-oriented midstream sector is in its infancy, mostly concentrated in few countries like Europe, America and South Korea. At present, most companies in the industry chain are basically in the red for years running due to huge R&D costs. Nevertheless, attracted by the tremendous market potential in the area of stem cell therapy and enjoying the great encouragement from government policies (e.g. capital subsidy) and the capital support of significant cooperative partners, very few companies have dropped out. Inquire for a Discount on this Report @ http://www.chinamarketresearchreports.com/contacts/inquiry.php?name=114908 .

  4. Global and China Stem Cell Industry Report, 2014-2017 Up to now, altogether 9 sorts of stem cell products have been approved worldwide, 3 of which are in the category of stem cell drugs developed by S. Korean companies, such as MEDIPOST’s adult stem cell drug CARTISTEM for osteoarthritis treatment and the stem cell product Prochymal (MEDIPOST obtained the product via acquiring the Therapeutics business of Osiris Therapeutics) direct at treating children suffering acute graft-versus-host disease (GVHD). On Aug. 19, 2014, Novartis reached an acquisition agreement with Gamida Cell (a corporate dedicated to stem cell technology R&D and its application in stem cell transplantation for leukemia patients), which specified that Novartis spend USD35 million in acquiring 15% equity in the latter and win the option to take over the remaining equity in two years with USD165 million; in Sep. 2013, Novartis also entered a cooperation with Regenerex to jointly develop the hematopoietic stem cell platform FCRx of the latter. Inquire Before Buying @http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114908 .

  5. Global and China Stem Cell Industry Report, 2014-2017 Related Released Market Reports of Research in China Global and China LED Industry Report, 2013-2014 LED saw a turning point in 2013 when Die (L0) and Package (L1) LED market size hit about USD15.188 billion, a rise of 8.3% from 2012. In 2014, the LED market will continue to recover with the market size of USD16.562 billion (up 9.0% from 2013). China Jewelry Industry Report, 2013-2016 In 2013, the global jewelry sales achieved USD184 billion, representing a year-on-year jump of 26.03% , accounting for 57.86% of the global luxury goods sales. In 2013, the jewelry sales in Chinese Mainland approximated USD75.8 billion (USD1= RMB6.2), equivalent to 41.2 % of the global consumption. Browse Life Sciences Reports @http://www.chinamarketresearchreports.com/cat/life-sciences.html .

  6. About us China Market Research Reports is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services.We provide 24/7 online and offline support to our customers.Website : www.chinamarketresearchreports.com Browse Latest Industry News, Updates, Trends, Opportunities, Scenario all over the world @ Call Now + 1 888 391 5441 | Email @sales@chinamarketresearchreports.com

More Related